Tuesday, March 31, 2020
Home Medical Cannabis News Cannabis & CBD Policy News

Cannabis & CBD Policy News

Medical Cannabis Network brings you the latest medical cannabis & CBD policy & regulation news from across the medicinal cannabis, CBD & THC sector.

Emerald Clinics: co-creating evidence with medical cannabis patients

Emerald Clinics: co-creating evidence with medical cannabis patients

Emerald Clinics CEO Dr Michael Winlo highlights the unique benefits of building real world evidence bases in patient-focussed clinical practice. Emerald Clinics' asks 'why haven’t...
New poll finds overwhelming public support for FSA CBD regulation

New poll finds overwhelming public support for FSA CBD regulation

A new YouGov poll commissioned by The Association for the Cannabinoid Industry (The ACI) demonstrates overwhelming support for recent FSA guidance concerning CBD and...
NHS urged to listen to new guidance on prescribing medical cannabis

NHS urged to listen to new guidance on prescribing medical cannabis

The NHS and UK Government are being urged to consider the new, expert guidance for prescribing medical cannabis put forward by the Medical Cannabis...
Calls for CBD regulation following inaccurate CBD levels on products

Calls for CBD regulation following inaccurate CBD levels on products

The Digital Citizens Alliance is calling on Congress for CBD regulation as new research has highlighted the inaccuracy of CBD potency levels listed on...
MEDCAN: patient support and advocacy in Switzerland

MEDCAN: patient support and advocacy in Switzerland

Franziska Quadri, President of the Medical Cannabis Association Switzerland (MEDCAN), tells MCN about MEDCAN’s advocacy work and the need for legislative change. Switzerland’s Medical Cannabis...
Dana Rohrabacher on evolving cannabis policy in America

Dana Rohrabacher on evolving cannabis policy in America

Former Republican politician, Dana Rohrabacher, has been a long-time advocate of medical cannabis in America. Here, Medical Cannabis Networks discusses evolving cannabis policy in...
Doctor prescribes medical cannabis in his practice

Medical cannabis import restrictions lifted for UK patients

Medical cannabis patients in the UK will now have faster access to their prescriptions thanks to new changes on import restrictions. The UK government has...
Illicit-vape deaths highlight urgency of legalising cannabis

Illicit-vape deaths highlight urgency of legalising cannabis

A report has highlighted how the vape death crisis underscores the importance and urgency of legalising cannabis nationwide. According to the report Cannabis Vaping: Opportunities...
Three reasons the Conservative government might legalise cannabis

Three reasons the Conservative government might legalise cannabis

In this article Ian Hamilton of the University of York and Harry Sumnall of Liverpool John Moores University discuss three reasons why the Conservative...
The evolution of the American cannabis industry in the last decade

The evolution of the American cannabis industry in the last decade

The American cannabis industry squinted into daylight as it emerged into a billion-dollar industry coming from a black market background. Since then, it is...
ProPharma: seven things to consider in medical cannabis development

ProPharma: seven things to consider in medical cannabis development

ProPharma Group takes a look at medical cannabis regulation and compliance. Jan Zorgdrager, PhD, and Marc Stegeman, MSc, Principal Consultants in ProPharma Group’s Life Sciences...
B3 Labs responds to FSA CBD deadline announcement

B3 Labs responds to FSA CBD deadline announcement

Last week The Food Standards Agency (FSA) formally issued a definitive timeline for Novel Food applications setting a deadline for the 31 March 2021...

Medical Cannabis eBooks

Medical Cannabis Partners

Pin It on Pinterest